Human insulin modulates a-synuclein aggregation via DAF-2/DAF-16 signalling pathway by antagonising DAF-2 receptor in C. elegans model of Parkinson's disease.
Haque R. Human insulin modulates a-synuclein aggregation via DAF-2/DAF-16 signalling pathway by antagonising DAF-2 receptor in C. elegans model of Parkinson's disease. Oncotarget. 2020 Feb 11; 11(6):634-649.